Home
About Us
Who We Are
Our Niche
Our Results
Recent Placements
Replacement Policy
Our Brochures
Our Team
Hot Jobs
Career Coaching
Resources
Recruiter Tips
Diversity Recruitment
News and Insights
Resume Resources
Contact Us

The Bandish Group

Home
About Us
Who We Are
Our Niche
Our Results
Recent Placements
Replacement Policy
Our Brochures
Our Team
Hot Jobs
Career Coaching
Resources
Recruiter Tips
Diversity Recruitment
News and Insights
Resume Resources
Contact Us
Jackie Bandish
September 11, 2018

Respiratory breakthrough for AstraZeneca

Jackie Bandish
September 11, 2018

AstraZeneca’s severe asthma drug, tezepelumab, has received breakthrough therapy designation from the FDA. Tezepelumab treats a broader respiratory population than AZ’s FasenraIt which could help boost the company in its battle with GlaxoSmithKline.

Click here to read the entire article.

Newer PostRegeneron expanding in New York
Older PostFirst “smart pill” ready to hit the market
Back to Top
Home
About Us
Who We Are
Our Niche
Our Results
Recent Placements
Replacement Policy
Our Brochures
Our Team
Hot Jobs
Career Coaching
Resources
Recruiter Tips
Diversity Recruitment
News and Insights
Resume Resources
Contact Us
The Bandish Group, LLC, 1432 Easton Road, Suite 2B, Warrington, PA, 18976, United States267-483-5233